Skip to main content
Signal8

Makker Gotham

SEC insider (Form 3/4/5 filer). CIK 0001726391. Director at ROCKET PHARMACEUTICALS, INC. (RCKT). 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 18, 2025. Located in CRANBURY, NJ.

Companies Makker Gotham has filed insider reports for

  • ROCKET PHARMACEUTICALS, INC. (RCKT): Director
Makker Gotham profile photo

Makker Gotham

CIK: 0001726391

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ROCKET PHARMACEUTICALS, INC. logo
RCKT

ROCKET PHARMACEUTICALS, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • ROCKET PHARMACEUTICALS, INC. logo
    RCKT

    ROCKET PHARMACEUTICALS, INC.

    Jun 18, 2025
    Award
    Indirect
    30K shares-
  • ROCKET PHARMACEUTICALS, INC. logo
    RCKT

    ROCKET PHARMACEUTICALS, INC.

    Jun 18, 2025
    Award
    Indirect
    19.4K shares-
  • ROCKET PHARMACEUTICALS, INC. logo
    RCKT

    ROCKET PHARMACEUTICALS, INC.

    Sep 26, 2024
    Award

    Stock Option (Right to Buy)

    Direct
    204 shares-
  • ROCKET PHARMACEUTICALS, INC. logo
    RCKT

    ROCKET PHARMACEUTICALS, INC.

    Sep 26, 2024
    Award

    Stock Option (Right to Buy)

    Direct
    303 shares-

1-4 of 4